PROVIDER PROFILE · NPI 1679580823

Danielle GrovesMD

Physical Medicine and RehabilitationEmerson, NJI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,064

Unique beneficiaries

—

Total services

3,630

Distinct HCPCS

Medicare payment

$156K

Peer benchmark

Total Medicare services vs. 424 Physical Medicine and Rehabilitation providers in NJ — above median (cohort median 2,034).

PRESCRIBING · PART D · 2024

Total Rx claims

1,205

Beneficiaries

—

Total drug cost

$63K

Distinct drugs

Brand share

22.6%

Top prescribed drugs

Pregabalin183 claims

Gabapentin174 claims

Meloxicam135 claims

Tramadol Hcl103 claims

Oxycodone Hcl/Acetaminophen94 claims

QUALITY · MIPS · 2024

Final MIPS score

96.1

Quality

86.9

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.89%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$307

Payment records

By payment type

Food and Beverage$291

Education$17

REFERRAL NETWORK

Where Danielle Groves's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Bloomfield Surgi-Center, Llc Ambulatory Surgical Center · Bloomfield, NJ	41	106
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	32	77
HMH HOSPITALS CORPORATION	17	68
Howard Baruch Orthopedic Surgery · Cliffside Park, NJ	12	17

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history